Suppr超能文献

甲状腺外科实践中的甲状腺微小乳头状癌:意外发现型与非意外发现型:一项十年对比研究

Papillary Thyroid Microcarcinoma in Thyroid Surgical Practice: Incidental vs. Non-Incidental: A Ten-Year Comparative Study.

作者信息

Bashir Amani A, El-Zaheri Mohamed M, Bashir Ahmad A, Fayyad Luma, Obed Aiman H, Alkam Dima, Bashir Abdalla Y

机构信息

Department of Pathology, University of Iowa Hospitals & Clinics, Iowa City, IA 52246, USA.

Department of Endocrinology, Ibn Sina University for Medical Sciences & Jordan Hospital, Amman 11152, Jordan.

出版信息

Cancers (Basel). 2025 Jun 18;17(12):2029. doi: 10.3390/cancers17122029.

Abstract

BACKGROUND/OBJECTIVES: With evolving guidelines favoring de-escalation in the management of papillary thyroid microcarcinoma (PTMC), options such as active surveillance and minimally invasive procedures are now considered for patients with low-risk disease. However, a subset of PTMCs-particularly non-incidental cases-may exhibit aggressive behavior. This study compares disease characteristics and outcomes between incidental and non-incidental PTMCs over a 10-year period.

METHODS

This is a single-center retrospective comparative analysis utilizing a prospectively collected database of patients referred for thyroid surgery.

RESULTS

Papillary thyroid carcinoma accounted for 86.7% of thyroid malignancies, with PTMC comprising 36.2% (137 patients). Incidental PTMC represented 109 out of 1012 patients undergoing surgery for benign thyroid disease (10.8%). Non-incidental PTMC (NIPTMC), diagnosed preoperatively and presenting clinically without coexisting thyroid disease, was identified in 28 patients (20.4%). NIPTMCs were more frequently associated with high-risk features (75% vs. 10.1%, = 0.004), including extrathyroidal extension (21.43% vs. 7.3% = 0.0015), positive central lymph nodes (21.43% vs. 2.8%, = 0.0291), positive lateral lymph nodes (28.6% vs. 0% = 0.012), and lymphovascular invasion (3.6% vs. 0%). Multifocal PTMC was seen in 37 patients (27%), of which 27 had bilobar disease. Multifocal tumors had a higher likelihood of high-risk features (48.6% vs. 14%, = 0.007). NIPTMC was a significant predictor of multifocality ( = 0.0098). All patients underwent surgery, none opted for active surveillance. NIPTMC is more often associated with high-risk features and multifocality, necessitating more extensive surgery. These findings emphasize the need for careful preoperative risk stratification to guide individualized management.

摘要

背景/目的:随着甲状腺微小乳头状癌(PTMC)管理中倾向于降阶梯治疗的指南不断发展,对于低风险疾病患者,现在会考虑诸如主动监测和微创手术等选择。然而,一部分PTMC,尤其是非偶发病例,可能表现出侵袭性。本研究比较了10年间偶发和非偶发PTMC的疾病特征和结局。

方法

这是一项单中心回顾性比较分析,利用前瞻性收集的甲状腺手术转诊患者数据库。

结果

甲状腺乳头状癌占甲状腺恶性肿瘤的86.7%,其中PTMC占36.2%(137例患者)。偶发PTMC占1012例接受良性甲状腺疾病手术患者中的109例(10.8%)。在28例患者(20.4%)中发现了术前诊断且临床上无并存甲状腺疾病的非偶发PTMC(NIPTMC)。NIPTMC更常与高风险特征相关(75%对10.1%,P = 0.004),包括甲状腺外侵犯(21.43%对7.3%,P = 0.0015)、中央淋巴结阳性(21.43%对2.8%,P = 0.0291)、侧方淋巴结阳性(28.6%对0%,P = 0.012)和脉管侵犯(3.6%对0%)。37例患者(27%)出现多灶性PTMC,其中27例为双侧病变。多灶性肿瘤具有高风险特征的可能性更高(48.6%对14%,P = 0.007)。NIPTMC是多灶性的重要预测因素(P = 0.0098)。所有患者均接受了手术,无人选择主动监测。NIPTMC更常与高风险特征和多灶性相关,需要更广泛的手术。这些发现强调了术前仔细进行风险分层以指导个体化管理的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77a/12190977/53c129f8705d/cancers-17-02029-g001.jpg

相似文献

6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma: A systematic review.
Clin Endocrinol (Oxf). 2023 Mar;98(3):296-305. doi: 10.1111/cen.14857. Epub 2022 Dec 12.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Analysis of Risk Factors for High-Risk Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Cancers (Basel). 2025 Aug 6;17(15):2585. doi: 10.3390/cancers17152585.

本文引用的文献

3
Is lobectomy sufficient for multifocal papillary thyroid microcarcinoma?
Am J Otolaryngol. 2023 Jul-Aug;44(4):103881. doi: 10.1016/j.amjoto.2023.103881. Epub 2023 Apr 5.
5
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4.
6
Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease.
Endocrine. 2022 Aug;77(2):325-332. doi: 10.1007/s12020-022-03089-6. Epub 2022 May 31.
7
Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis.
J Am Coll Surg. 2021 Oct;233(4):537-544. doi: 10.1016/j.jamcollsurg.2021.06.011. Epub 2021 Jul 12.
8
Papillary thyroid microcarcinomas that metastasize to lymph nodes.
Am J Otolaryngol. 2021 Sep-Oct;42(5):103023. doi: 10.1016/j.amjoto.2021.103023. Epub 2021 Mar 31.
9
The Optimal Parathyroid Hormone Cut-Off Threshold for Early and Safe Management of Hypocalcemia After Total Thyroidectomy.
Endocr Pract. 2021 Sep;27(9):925-933. doi: 10.1016/j.eprac.2021.02.014. Epub 2021 Feb 27.
10
Wolf in Sheep's Clothing: Papillary Thyroid Microcarcinoma in the US.
J Am Coll Surg. 2020 Apr;230(4):484-491. doi: 10.1016/j.jamcollsurg.2019.12.036. Epub 2020 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验